Status | Study |
Active, not recruiting |
Study Name: Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma Condition: Renal Cell Carcinoma Date: 2012-12-22 Interventions: Drug: Sorafenib Sorafenib 400m |
Completed |
Study Name: A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ Condition: Ductal Carcinoma in Situ Date: 2012-06-20 Interventions: Dietary Supplement: Black cohosh Remifemin 20 mg tablet orally twice per day x 4 weeks |
Completed |
Study Name: Contribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast Cancer Condition: Infiltrating Ductal Carcinoma Date: 2012-06-14 |
Completed |
Study Name: Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer Condition: Female Breast Neoplasms Carcinoma, Ductal, Breast Date: 2011-12-15 Interventions: Procedure: axillary dissection Conservative breast surgery with or without axillary dissection |
Active, not recruiting |
Study Name: The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer Condition: Mammary Ductal Carcinoma Date: 2011-11-30 |
Terminated |
Study Name: Diagnostic Study of Early Breast Cancer Using Ultrasound Condition: Ductal Carcinoma In-situ Date: 2011-06-15 Interventions: Drug: Perflutren lipid microsphere Intravenous injection of 10 microL/kg once prior to ultrasound examin |
Terminated |
Study Name: A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ Condition: Ductal Carcinoma in Situ Date: 2010-01-29 Interventions: Drug: Polyphenon E three 200mg capsules (600mg total dose of the study drug) with food (within one hour |
Terminated |
Study Name: Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma Condition: Non-curative Resectable Bile Duct Carcinoma Date: 2009-11-16 Interventions: Drug: Temoporfin Drug treatment: Temoporfin 0.15 mg/kg bod |
Terminated |
Study Name: Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast Condition: Ductal Carcinoma in Situ Date: 2009-03-06 Interventions: Drug: lapatinib 1500 mg lapatinib for 14-21 days Oth |
Completed |
Study Name: Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) Condition: Ductal Carcinoma In Situ Date: 2008-04-28 Interventions: Drug: Carboplatin i.d. Days 1 & 15 |